Randomised trials of STD treatment for HIV prevention: Report of an international workshop

Genitourinary Medicine

Volumn 73, Issue 6, 1997, Pages 432-443

  Hayes, Richard ^a,b,c,d   Wawer, Maria ^a   Gray, Ron ^a   Whitworth, James ^a,b   Grosskurth, Heiner ^a,c   Mabey, David ^a,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c MRC Programme on AIDS in Uganda   (Uganda)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Community trials; HIV prevention; STD treatment

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; METRONIDAZOLE;

CLINICAL EXAMINATION; CONFERENCE PAPER; GONOCOCCAL URETHRITIS; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; MEDICAL ETHICS; NONSPECIFIC URETHRITIS; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; RURAL POPULATION; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; TANZANIA; TRICHOMONIASIS; UGANDA; VAGINA DISCHARGE;

COMMUNITY HEALTH SERVICES; ETHICS, MEDICAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MICROBIOLOGICAL TECHNIQUES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SPECIMEN HANDLING; UROLOGIC DISEASES;

EID: 79959952663     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (66)

1. The Status and Trends of the Global HIV/AIDS Pandemic Symposium Final Report, Vancouver, 5-6 July 1996. Harvard, MA: AIDSCAP/Family Health International, Harvard School of Public Health and UNAIDS, 1996.
2. Mann J, Tarantola DJM, Netter TW, eds. AIDS in the world. Cambridge, MA: Harvard University Press, 1992.
3. Laga M, Diallo MO, Buvé A. Inter-relationship of sexually transmitted diseases and HIV: where are we now? AIDS 1994;8 (suppl 1):S119-24.
4. Wasserheit JN. Interrelationships between human immunodeficiency virus infections and other sexually transmitted disease. Sex Transm Dis 1992;19:61-77.
5. DeSchryver A, Meheus A. Epidemiology of sexually transmitted diseases: the global picture. Bull WHO 1990;68:639-54.
6. Over M, Piot P. HIV infection and sexually transmitted diseases. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL, eds. Disease control priorities in developing countries. New York: Oxford University Press, 1993:455-527
7. World Bank. World development report 1993: investing in health. New York: Oxford University Press, 1993.
8. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-6.
9. Mertens T, Hayes RJ, Smith PG. Epidemiologic methods to study the interaction between HIV infection and other sexually transmitted diseases. AIDS 1990;4:57-65.
10. Mayaud P, Grosskurth H, Changalucha J, et al. Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics. Bull WHO 1995;73:621-30.
11. Mulder D. Disease perception and health-seeking behaviour for sexually transmitted diseases. In: Prevention and management of sexually transmitted diseases in eastern and southern Africa: current approaches and future directions. Nairobi: NARESA Monograph No 3, NARESA, PO 1177 I.Nairobi, 1994.
12. Newell J, Senkoro K, Mosha F, et al. A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 2. Risk factors and health seeking behaviour. Genitourin Med 1993;69:421-6.
13. Grosskurth H, Mayaud P, Mosha F, et al. Asymptomatic gonorrhea and chlamydia infection in rural Tanzanian men. BMJ 1996;312:277-90.
14. Buvé A, Mosha F, Watson-Jones D, et al. Is asymptomatic urethritis in men an obstacle to effective STD control? A community study in Mwanza, Tanzania. XI International Conference on AIDS, Vancouver, July 1996, abstract No C341.
15. Ka-Gina G, Grosskurth H, Mwijarubi E, et al. The feasibility of integrating STD management into a rural primary health care system: results from a large scale intervention study in Mwanza, Tanzania, llth Meeting of International Society for STD Research, New Orleans, August 1995, abstract No 081.
16. Mwijarubi E, Grosskurth H, Mosha F, et al. Improved STD treatment significantly reduces prevalence of syphilis and symptomatic urethritis in rural Tanzania. XI International Conference on AIDS, Vancouver, July 1996, abstract No LB C 6062.
17. Vuylsteke B, Laga M, Alary M, et al. Clinical algorithms for the screening of women for gonococcal and chlamydial infection: evaluation of pregnant women and prostitutes in Zaire. Clin Infect Dis 1993;17:82-8.
18. Hethcote HH, Yorke JA. Gonorrhea transmission dynamics and control. Lecture notes in biomathematics. New York: Springer, 1984.
19. Hayes R, Mosha F, Nicoll A, et al. A community trial of the impact of improved STD treatment on the HIV epidemic in rural Tanzania: 1 Design. AIDS 1995;9:919-26.
20. Smith PG, Morrow RH. Field trials of health intervention in developing countries: a tool box. London: Macmillan, 1996.
21. Grosskurth H, Mosha F, Todd J, et al. A community trial of the impact of improved STD treatment on the HIV epidemic in rural Tanzania: 2 Baseline survey results. AIDS 1995;9:927-34.
22. Kengeya-Kayondo JF, Nabaitu J, Malamba S, Whitworth J. A trial of IEC alone and with improved STD care on HIV incidence in Uganda: are study communities comparable? XI International Conference on AIDS, Vancouver, July 1996, abstract No We C 3527.
23. Dormer A, Klar N. Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. Am J Epidemiol 1994;140:279-89.
24. Donner A, Donald A. Analysis of data arising from a stratified design with the cluster as unit of randomization. Stat Med 1987;6:43-52.
25. Gail MH, Mark SD, Carroll RJ, Green SB, Pee D. On design considerations and randomization-based inference for community intervention trials. Stat Med 1996;15:1069-92.
26. Airman DG, Doré CJ. Randomisation and baseline comparison in clinical trials. Lancet 1990;335:49-153.
27. Senn S. Testing for baseline balance in clinical trials. Stat Med 1994;13:1715-26.
28. Hayes R, Grosskurth H, ka-Gina G. Impact of improved treatment of sexually transmitted disease on HIV infection. Lancet 1995;346:1159-60.
29. Wawer M, Sewankambo NK, Gray RH, et al. Community-based trial of mass STD treatment for HIV control, Rakai, Uganda: preliminary data on STD declines. XI International Conference on AIDS, Vancouver, July 1996, abstract No C443.
30. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-transmission in women: results from a cohort study. AIDS 1993;7:95-102.
31. Paxton LA, Sewankambo N, Wawer MJ, et al. Asymptomatic genital tract infections in a rural district of Uganda. XI International Conference on AIDS, Vancouver, July 1996, abstract No C340.
32. Holmes KK, Mardh P, Sparling PH, a al, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990.
33. Hillier S, Arko R. Vaginal infections. In: Morse SA, Moreland AA, Holmes KK, eds. Atlas of sexually transmitted diseases and AIDS. 2nd ed. London: Mosby-Wolfe, 1996.
34. Wawer MJ, McNairn D, Wabwire-Mangen F, et al. Self-administered vaginal swabs for population-based assessment of Trichomonas vaginalis prevalence. Lancet 1995;345:131-2.
35. Borchardt DA, Smith RF. An evaluation of an InPouch TV culture method for diagnosing Trichomonas vaginalis infection. Genitourin Med 1991;67:149-52.
36. Draper D, Parker R, Patterson E, et al. Detection of Trichomonas vaginalis in pregnant women with the InPouch TV Culture System. J Clin Microbiol 1993;31:1016-8.
37. Bertholf ME, Stafford MJ. Colonization of Candida albicans in vagina, rectum and mouth. J Family Pract 1983;16:919.
38. Eschenbach DA, Hillier SL, Critchlow C, et al. Diagnosis and clinical manifestations of bacterial vaginosis Am J Obstet Gynecol 1988;158:819-28.
39. Alfa M, Olson N, Degagne P, et al. Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi. J Infect Dis 1993;167:1206-10.
40. Desjardins M, Thompson R, Filion LG, et al. Standardisation of an enzyme immuno assay for human antibody to Haemophilus ducreyi. J Clin Microbiol 1992;30:2019-24.
41. Museyi K, VanDyck E, Vervoort T, et al. Use of an enzyme immunoassay to detect serum IgG antibodies to Haemophilus ducreyi. J Infect Dis 1988;157:1039-43.
42. Roggen E, Hoofd G, Van Dyck E, Piot P. Enzyme immunoassays (EIAs) for the detection of Haemophilus ducreyi serum IgA, IgG and IgM antibodies. Sex Transm Dis 1994;21:36-42.
43. Cowan FM, Johnson AM, Ashley RL, Corey L, Mindel A. Antibody to HSV2 as a serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
44. Wagner HU, Van Dyck E, Roggen E, et al. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. IntJSTDAIDS 1994;5:332-7.
45. Orle KA, Gates CA, Martin DH, Body BA, Weiss JB. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum and Herpes simplex virus types 1 and 2 from genital ulcer. J Clin Microbiol 1996;34:49-54.
46. McNagny SE, Parker RM, Zenilman JM, Lewis JS. Urinary leucocyte esterase test: a screening method for the detection of asymptomatic chlamydial and gonococcal infections in men. J Infect Dis 1992;165:573-6.
47. Mayaud P, Changalucha J, Grosskurth H, et al. The value of urine specimens in screening for male urethritis and its microbial aetiologies in Tanzania. Genitourin Med 1992;68:361-5.
48. Ching S, Lee H, Hook EW, Jacobs MR, Zenilman J. Ligase chain reaction for detection of Neisseria gonorrhoeas in urogenital swabs. J Clin Microbiol 1995;33:3111-4.
49. Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995;345:213-6.
50. Buimer M, Van Doornum GJ, Ching S, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening. J Clin Microbiol 1996;34:2395-400.
51. Chernesky MA, Lee H, Schachter J, et al. Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis 1994;170:1308-11.
52. World Health Organisation. Management of sexually transmitted diseases. (WHO/GPA/TEM/94-1.) Geneva: World Health Organisation, 1994.
53. Braddick MR, Ndinya-Achola JO, Mirza NB, et al. Towards developing a diagnostic algorithm for Chlamydia trachomatis and Neisseria gonorrhoeae cervicitis in pregnancy. Genitourin Med 1990;66:62-5.
54. Ballard R, Morse S. Chancroid. In: Morse SA, Moreland AA, Holmes KK, eds. Atlas of sexually transmitted diseases and AIDS. 2nd ed. London: Mosby-Wolfe, 1996.
55. Steingrimsson O, Olafsson JH, Throrarinsson J, et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chem 1990;25 (suppl A):109-14.
56. Ballard R, Radebe F, Mampuru M, Dangor Y, Fehler HG. A comparison of ofloxacin and ciprofloxacin in the treatment of chancroid. Sex Transm Dis 1994;21 (Suppl 2, Abst 110):S189.
57. Echols RM, Heyd A, O'Keeffe BJ, Schacht P. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary. Sex Transm Dis 1994;21:345-52.
58. Martin DH, Mroczkowski TF, Dalu AA, et al. A controlled trial of single dose azithromycin for the treatment of chlamydial urethritis and cervicitis. N EngI J Med 1992;327:921-5.
59. Handsfield HH, McCormack WM, Hook EW, et al. A comparison of single dose cefixime with ceftriaxone as treatment of uncomplicated gonorrhea. N Engl J Med 1991;325:1337-41.
60. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995;172:525-9.
61. Sweet RL. New approaches for the treatment of bacterial vaginosis. Am J Obstet Gynecol 1993;169:479-82.
62. Verdon MS, Hunter Handsfield H, Johnson RB. Pilot study of azithromycin for treatment of primary and secondary syphilis. Clin Infect Dis 1994;19:486-8.
63. Zenilman JM. Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994: what was the impact of ciprofloxacin as first line therapy for gonorrhea? Sex Transm Dis 1996;23:213-8.
64. Pena C, Albareda JM, Pallares R, et al. Relationship between quinolone use and emergence of ciprofloxacin resistant E coli in bloodstream infections. Antimicrob Agents Chemother 1995;39:520-4.
65. Havlir DV, Dube MP, Sattler FR, et al. Prophylaxis against disseminated Mycobaaerium avium complex with weekly azithromycin, daily rifabutin, or both. N Engl J Med 1996;335:392-8.
66. Temmerman M, Ndinya-Achola J, Ambani J, Piot P. The right not to know HIV-test results. Lancet 1995;345-969-70.